Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 701720 of 20,252 grants

Active NON-SBIR/STTR RPGS
Gut Microbiome Profiles in Association with Breast Cancer Recurrence and Mortality
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2024 – 2026

PROJECT SUMMARY While breast cancer prognosis has substantially improved over the last three decades, recurrence remains a significant risk, particularly for African American patie...

$1.75M
USD
Active NON-SBIR/STTR RPGS
CROSSTALK BETWEEN GUT MICROBIOTA AND HEPATOCELLULAR CARCINOMA INDUCED BY METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2024 – 2026

Metabolic dysfunction-associated steatotic liver disease (MASLD) is considered a world-wide public health problem caused by metabolic syndrome. It is estimated that 30% of the worl...

$4.26M
USD
Active NON-SBIR/STTR RPGS
Nonresponse of Patient-reported Outcomes in Routine Cancer Care
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Patient-reported outcome (PRO) measures, or PROMs, are powerful tools in cancer care to enhance clinician- patient communication, identify problematic symp...

$1.79M
USD
Active NON-SBIR/STTR RPGS
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
NATIONAL CANCER INSTITUTE Sanford Burnham Prebys Medical Discovery... United States 2024 – 2031

Summary This R35 focuses on novel mechanisms underlying control of key UPR components that impact melanoma metastasis in aged rather than young mice by (i) tumor-intrinsic mechanis...

$11.7M
USD
Active NON-SBIR/STTR RPGS
Elucidating T Cell Ferroptosis in Renal Medullary Carcinoma: 3D Genome Architecture Rewiring and Therapeutic Alleviation
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

Project Summary The three-dimensional (3D) chromatin architecture in mammals represents a remarkable yet not fully understood biological process. The high-throughput chromosome con...

$6.87M
USD
Active NON-SBIR/STTR RPGS
Modulating cysteine metabolism to induce cell death in small cell lung cancer
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2029

SUMMARY Small cell lung cancer (SCLC) is a fatal form of lung cancer whose development is closely associated with tobacco smoking. Patients with SCLC have a median overall survival...

$5.31M
USD
Active NON-SBIR/STTR RPGS
Harnessing DNA methylation in peripheral blood for improved colorectal cancer prevention
NATIONAL CANCER INSTITUTE Harvard School of Public Health United States 2024 – 2028

PROJECT SUMMARY / ABSTRACT DNA methylation (DNAm) aberrancies are hallmarks of colorectal cancer (CRC) and substantially outnumber somatic mutations. So far, most DNAm studies have...

$7M
USD
Active NON-SBIR/STTR RPGS
Epigenetic mechanisms controlling single-stranded DNA lesion sensitivity and mutagenesis
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2029

Project Summary: Our long-term objective is to define the epigenetic mechanisms that ensure accurate genome maintenance, and to exploit these findings to improve human health. Sing...

$5.22M
USD
Active NON-SBIR/STTR RPGS
CPMV-Polymer Devices to Enhance the Outcomes of Intratumoral Immunotherapy
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2024 – 2029

CPMV-Polymer Devices to Enhance the Outcomes of Intratumoral Immunotherapy Steinmetz (PI) and her colleagues have developed a plant virus nanoparticle immunotherapy that activates...

$6.19M
USD
Active NON-SBIR/STTR RPGS
Kinase Signaling in Epidermal Homeostasis and Early Neoplasia
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2029

PROJECT SUMMARY Kinases are essential to development and deregulation of their activity contributes to cancer progression in multiple human malignancies. We recently demonstrated t...

$4.79M
USD
Active NON-SBIR/STTR RPGS
A Mechanoimmunological Basis for Metastatic Site Preference
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

Summary Antitumor immunosurveillance by cytotoxic lymphocytes is generally conceived as a biochemical process in which tumor specific markers are recognized by activating receptors...

$5.77M
USD
Active NON-SBIR/STTR RPGS
Colorectal Cancer Screening with Optical Coherence Tomography
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

The overall incidence rate of colorectal cancer (CRC) has declined over the past two decades largely due to population-based colonoscopic screening for and removal of precursor ade...

$7.11M
USD
Active NON-SBIR/STTR RPGS
Novel PET Imaging to Guide Therapy in Hepatocellular Carcinoma
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT: Novel PET Imaging to Guide Therapy in Hepatocellular Carcinoma Liver cancer is the third leading cause of cancer death worldwide, with hepatocellular carc...

$6.79M
USD
Active NON-SBIR/STTR RPGS
Randomized controlled trial of FoRtitude: Targeted eHealth intervention to reduce fear of recurrence among breast cancer survivors in community oncology settings
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2024 – 2029

PROJECT SUMMARY Fear of recurrence (FoR) is a pervasive, distressing concern among breast cancer survivors (BCS) that persists for years after cancer treatment. Long-term survivors...

$7.09M
USD
Active NON-SBIR/STTR RPGS
Regulation of Nuclear Akt by p53, MDM2 and Phosphoinositide Lipids Roles in Oncogenic Transformation and Tumor Progression
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2029

PROJECT SUMMARY: 30 lines. The canonical phosphoinositide (PI) 3-kinase (PI3K)/Akt signaling pathway uses free membrane PI lipid to regulate cell growth and is frequently hyperacti...

$5.69M
USD
Active NON-SBIR/STTR RPGS
CD200R blockade for cancer immunotherapy
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2029

PROJECT SUMMARY Immunotherapies based on the blockade of immune checkpoints have revolutionized cancer treatment in recent years. Today, immune checkpoint inhibitors in development...

$5.59M
USD
Active NON-SBIR/STTR RPGS
Dissecting and targeting PAK4 in Ewing sarcoma
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2029

Ewing sarcoma (ES) is the second most common bone tumor in the pediatric population and is defined by a pathognomonic translocation, most frequently EWS::FLI1, which leads to the e...

$4.37M
USD
Active NON-SBIR/STTR RPGS
Targeting DHX9 to trigger viral mimicry and immunotherapy responsiveness in Small Cell Lung Cancer (SCLC)
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2024 – 2029

PROJECT SUMMARY / ABSTRACT Despite the impressive clinical success of Immune checkpoint blockade (ICB) therapy in cancer, therapy resistance is common and only a small subset of pa...

$6.5M
USD
Active NON-SBIR/STTR RPGS
Intratumoral microbiota and immune predictors of response to immunotherapy in lung cancer
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2024 – 2029

ABSTRACT Although immunotherapy, especially immune checkpoint inhibitors (ICIs), has emerged as a powerful cancer treatment, less than half of advanced Non-Small Cell Lung Cancer (...

$6.84M
USD
Active NON-SBIR/STTR RPGS
Clinical decision-support algorithms for interactive design of patient-specific breast molds
NATIONAL CANCER INSTITUTE University of Houston United States 2024 – 2028

Breast reconstruction can help feminine-presenting individuals retain or regain quality of life by mitigating the impacts of body image disruption due to appearance changes arising...

$6.65M
USD